These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4. Katz G; Markel G; Mizrahi S; Arnon TI; Mandelboim O J Immunol; 2001 Jun; 166(12):7260-7. PubMed ID: 11390475 [TBL] [Abstract][Full Text] [Related]
3. Natural killer cell recognition of HLA class I molecules. Brooks AG; Boyington JC; Sun PD Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749 [TBL] [Abstract][Full Text] [Related]
4. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. Rajagopalan S; Long EO J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900 [TBL] [Abstract][Full Text] [Related]
5. Structure and function of natural killer cell surface receptors. Radaev S; Sun PD Annu Rev Biophys Biomol Struct; 2003; 32():93-114. PubMed ID: 12471063 [TBL] [Abstract][Full Text] [Related]
6. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671 [TBL] [Abstract][Full Text] [Related]
7. A HLA-Cw6 specific single-chain antibody fragment (scFv) recognizing a natural killer cell receptor epitope. Marget M; Bohlsen D; Davarnia P; Yoo-Ott K; Kabelitz D; Skerra A; Steinmann J Mol Immunol; 2005 Mar; 42(5):643-9. PubMed ID: 15607823 [TBL] [Abstract][Full Text] [Related]
8. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Fan QR; Garboczi DN; Winter CC; Wagtmann N; Long EO; Wiley DC Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7178-83. PubMed ID: 8692965 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. Maenaka K; Juji T; Stuart DI; Jones EY Structure; 1999 Apr; 7(4):391-8. PubMed ID: 10196125 [TBL] [Abstract][Full Text] [Related]
10. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Boyington JC; Sun PD Mol Immunol; 2002 May; 38(14):1007-21. PubMed ID: 11955593 [TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors. Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968 [TBL] [Abstract][Full Text] [Related]
12. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Diefenbach A; Hsia JK; Hsiung MY; Raulet DH Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935 [TBL] [Abstract][Full Text] [Related]
14. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor. Lian RH; Freeman JD; Mager DL; Takei F J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224 [TBL] [Abstract][Full Text] [Related]
15. Reduced KIR2DL1 recognition of MHC class I molecules presenting phosphorylated peptides. Betser-Cohen G; Katz G; Gonen-Gross T; Stern N; Arnon TI; Achdout H; Gazit R; Mandelboim O J Immunol; 2006 Jun; 176(11):6762-9. PubMed ID: 16709835 [TBL] [Abstract][Full Text] [Related]
16. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Fan QR; Long EO; Wiley DC Nat Immunol; 2001 May; 2(5):452-60. PubMed ID: 11323700 [TBL] [Abstract][Full Text] [Related]
18. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors. Kim J; Chwae YJ; Kim MY; Choi IH; Park JH; Kim SJ J Immunol; 1997 Oct; 159(8):3875-82. PubMed ID: 9378975 [TBL] [Abstract][Full Text] [Related]
19. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Valés-Gómez M; Reyburn HT; Erskine RA; Strominger J Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14326-31. PubMed ID: 9826699 [TBL] [Abstract][Full Text] [Related]
20. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Radaev S; Rostro B; Brooks AG; Colonna M; Sun PD Immunity; 2001 Dec; 15(6):1039-49. PubMed ID: 11754823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]